---

---

symbols : AZNCF    crawled time : 14:00   

save search

---

Ionis announces new chief global product strategy officer to lead next phase of commercial growth
Published: 2024-02-29 (Crawled : 14:00) - prnewswire.com
AZNCF | $135.305 -4.19% 1.1K |

Health Technology

| 3.29% | O: -3.11% H: 0.0% C: -0.24%
IONS | $40.93 -1.47% -1.49% 1.1M |

Health Technology

| -10.74% | O: 0.82% H: 0.33% C: -3.64%
AZN | $68.53 0.39% 0.39% 3.7M |

Health Technology

| 4.46% | O: -0.28% H: 0.06% C: -1.55%
global commercial growth

---

Rakovina Therapeutics Announces Appointment of New Scientific Advisory Board Member
Published: 2023-11-20 (Crawled : 14:00) - globenewswire.com
AZNCF | $135.305 -4.19% 1.1K |

Health Technology

| 5.71% | O: 0.04% H: 0.0% C: -1.49%
AZN | $68.53 0.39% 0.39% 3.7M |

Health Technology

| 6.45% | O: -1.39% H: 1.02% C: 0.87%
therapeutics

---

Artelo Biosciences Announces Publication of New Peer-Reviewed Research Demonstrating Protective Properties of ART27.13 Against Muscle Degeneration Caused by Certain Cancers
Published: 2023-11-09 (Crawled : 14:00) - globenewswire.com
AZNCF | $135.305 -4.19% 1.1K |

Health Technology

| 8.17% | O: 2.33% H: 0.83% C: -0.88%
AZN | $68.53 0.39% 0.39% 3.7M |

Health Technology

| 7.45% | O: 2.72% H: 0.49% C: -1.79%
ARTL | $1.3 -10.35% -11.54% 46K |

Health Technology

| 0.69% | O: 3.47% H: 0.0% C: -11.41%
art27 art27.13 publication research

---

American Red Cross Elects Aradhana Sarin as New Member to National Board of Governors
Published: 2023-07-13 (Crawled : 14:00) - prnewswire.com
AZNCF | $135.305 -4.19% 1.1K |

Health Technology

| 0.73% | O: -0.24% H: 0.0% C: -0.3%
AZN | $68.53 0.39% 0.39% 3.7M |

Health Technology

| 2.7% | O: 1.47% H: 0.52% C: 0.39%

---

Gene Therapy Company Genprex, Inc. (NASDAQ: GNPX) Receives Fast Track Designation From The FDA For Its Small Cell Lung Cancer Drug Candidate
Published: 2023-07-11 (Crawled : 14:00) - biospace.com/
GNPX | $2.26 -1.74% -1.77% 21K |

Health Technology

| 164.64% | O: 1.25% H: 3.41% C: -1.43%
AZN | $68.53 0.39% 0.39% 3.7M |

Health Technology

| 4.72% | O: -0.28% H: 0.25% C: -0.23%
fda lung drug candidate cancer cell designation therapy fast track designation

---

Genprex Receives U.S. FDA Fast Track Designation for REQORSA® Immunogene Therapy in Combination with Tecentriq® for the Treatment of Small Cell Lung Cancer
Published: 2023-06-28 (Crawled : 14:00) - biospace.com/
AZNCF | $135.305 -4.19% 1.1K |

Health Technology

| -5.22% | O: 0.74% H: 0.0% C: -2.36%
GNPX | $2.26 -1.74% -1.77% 21K |

Health Technology

| 210.77% | O: 14.85% H: 1.18% C: -7.27%
AZN | $68.53 0.39% 0.39% 3.7M |

Health Technology

| -4.75% | O: -0.29% H: 0.13% C: -0.7%
reqorsa fda lung cancer cell treatment designation therapy fast track designation

---

Injection Pen Market Size is Projected To Reach USD 80,511.51 Million By 2031, Growing at a CAGR of 7.8% | Valuates Reports
Published: 2023-05-23 (Crawled : 14:00) - prnewswire.com
AZNCF | $135.305 -4.19% 1.1K |

Health Technology

| -8.52% | O: 0.7% H: 1.22% C: -0.67%
NONOF | $122.742 0.31% 6.5K |

Health Technology

| -27.79% | O: 0.01% H: 0.0% C: -3.5%
LLY | News | $750.77 0.54% -0.04% 3.1M |

Health Technology

| 72.06% | O: -0.25% H: 0.69% C: -2.24%
SNY | News | $46.125 0.71% 0.7% 3.7M |

Health Technology

| -15.6% | O: -0.01% H: 0.0% C: 0.0%
AZN | $68.53 0.39% 0.39% 3.7M |

Health Technology

| -8.31% | O: 0.97% H: 0.0% C: -1.46%
reach growing injection market

---

Fortress Biotech to Participate in Two March 2023 Investor Conferences
Published: 2023-03-07 (Crawled : 14:00) - globenewswire.com
AZNCF | $135.305 -4.19% 1.1K |

Health Technology

| 3.92% | O: -2.57% H: 1.62% C: 1.62%
FBIO | $1.79 1.7% 1.68% 240K |

Health Technology

| 117.28% | O: 0.0% H: 3.69% C: 2.72%
AZN | $68.53 0.39% 0.39% 3.7M |

Health Technology

| 5.74% | O: 0.9% H: 0.28% C: -1.3%
biotech

---

Helocyte, Inc. Announces Positive Data from Stem Cell Transplant Donor Vaccination Trial to be Presented at the 2023 Tandem Meetings: Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR
Published: 2023-02-16 (Crawled : 14:00) - globenewswire.com
AZNCF | $135.305 -4.19% 1.1K |

Health Technology

| -3.89% | O: -2.87% H: 0.88% C: 0.88%
FBIO | $1.79 1.7% 1.68% 240K |

Health Technology

| 137.04% | O: 0.81% H: 5.54% C: 3.66%
AZN | $68.53 0.39% 0.39% 3.7M |

Health Technology

| -2.04% | O: -2.65% H: 1.22% C: 0.16%
cibmtr trial positive therapy

---

Global Pharmacogenomics Market Analysis Report 2022: A $10.5+ Billion Market by 2026 - Long-term Forecast to 2031
Published: 2022-11-23 (Crawled : 14:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| 23.47% | O: 1.83% H: 0.0% C: 0.0%
AZNCF | $135.305 -4.19% 1.1K |

Health Technology

| 3.98% | O: 1.44% H: 1.0% C: -1.09%
TMO | News | $547.25 -1.32% -0.02% 1.6M |

Health Technology

| 2.61% | O: 1.02% H: 0.0% C: 0.0%
GSK | $39.6 -0.88% 0.0% 2.8M |

Health Technology

| 18.02% | O: -0.53% H: 0.59% C: 0.06%
ABT | News | $105.9 -3.03% 0.07% 12M |

Health Technology

| 4.14% | O: 0.1% H: 1.43% C: 1.0%
AZN | $68.53 0.39% 0.39% 3.7M |

Health Technology

| 3.43% | O: 0.41% H: 0.24% C: -0.23%
global report market

---

Artelo Biosciences Reports Third Quarter 2022 Financial Results and Provides Business Update
Published: 2022-11-08 (Crawled : 14:00) - biospace.com/
AZNCF | $135.305 -4.19% 1.1K |

Health Technology

| 12.55% | O: 2.49% H: 0.0% C: -1.6%
AZN | $68.53 0.39% 0.39% 3.7M |

Health Technology

| 11.73% | O: 0.2% H: 0.96% C: 0.18%
ARTL | $1.3 -10.35% -11.54% 46K |

Health Technology

| -47.08% | O: 0.0% H: 4.74% C: 4.74%
financial update results

---

Red Biotechnology Market to Exceed US$ 609.6 Bn by 2031: TMR Study
Published: 2022-08-19 (Crawled : 14:00) - prnewswire.com
AZNCF | $135.305 -4.19% 1.1K |

Health Technology

| 3.94% | O: 3.04% H: 0.12% C: -2.22%
TAK | $13.15 -0.61% 0.0% 1.6M |

Health Technology

| -6.7% | O: -2.05% H: 0.29% C: 0.07%
PFE A | $25.42 -1.05% -0.04% 44M |

Health Technology

| -47.12% | O: 0.54% H: 1.24% C: 0.63%
BMY | $47.84 -0.87% -0.02% 12M |

Health Technology

| -34.92% | O: 0.01% H: 2.09% C: 1.58%
REGN | $901.27 0.8% 0.78% 470K |

Health Technology

| 43.1% | O: -0.62% H: 0.57% C: -0.42%
GILD | $66.94 -0.55% -0.55% 5.3M |

Health Technology

| 3.27% | O: -0.25% H: 1.19% C: 0.49%
AZN | $68.53 0.39% 0.39% 3.7M |

Health Technology

| 2.65% | O: 0.78% H: 0.49% C: 0.22%
study market

---

Fortress Biotech Subsidiary Helocyte Announces Grant that Could Provide Over $20 Million from National Institute of Allergy and Infectious Diseases for Phase 2 Study of Triplex
Published: 2022-08-11 (Crawled : 14:00) - biospace.com/
AZNCF | $135.305 -4.19% 1.1K |

Health Technology

| 2.17% | O: -0.07% H: 0.12% C: -2.89%
FBIO | $1.79 1.7% 1.68% 240K |

Health Technology

| 45.45% | O: 0.83% H: 7.38% C: 5.74%
AZN | $68.53 0.39% 0.39% 3.7M |

Health Technology

| 2.96% | O: -1.89% H: 0.0% C: -0.61%
biotech grant study phase 2

---

Global Cough Syrup Market Report (2022 to 2028) - Featuring AstraZeneca, Abbott Laboratories, Acella Pharmaceuticals and Glenmark Pharmaceuticals Among Others
Published: 2022-07-01 (Crawled : 14:00) - prnewswire.com
RBGPF | $50.822 6.46% 2.7K |

Consumer Non-Durables

| -30.34% | O: 0.2% H: 4.46% C: 0.03%
AZNCF | $135.305 -4.19% 1.1K |

Health Technology

| 4.96% | O: -3.88% H: 6.2% C: 5.52%
RBGLY | $10.34 -2.05% 2.8M |

Manufacturing

| -32.11% | O: -1.05% H: 1.59% C: 1.53%
ABT | News | $105.9 -3.03% 0.07% 12M |

Health Technology

| 0.66% | O: -0.04% H: 0.0% C: 0.0%
SNY | News | $46.125 0.71% 0.7% 3.7M |

Health Technology

| -8.57% | O: 0.26% H: 0.0% C: 0.0%
AZN | $68.53 0.39% 0.39% 3.7M |

Health Technology

| 3.32% | O: -2.92% H: 0.0% C: 0.0%
report market

---

Biologic Therapy Market Information: By Product and Geography - Global Forecast till 2025
Published: 2022-06-17 (Crawled : 14:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| -21.51% | O: 0.01% H: 0.17% C: 0.17%
SNYNF | News | $92.116 -2.18% 2.3K |

Health Technology

| -5.19% | O: -1.76% H: 5.75% C: 5.5%
AZNCF | $135.305 -4.19% 1.1K |

Health Technology

| 13.94% | O: 1.89% H: 0.0% C: -0.64%
NVSEF | News | $93.6375 6.88% 82K |

Health Technology

| 38.93% | O: 0.74% H: 0.52% C: -3.23%
NVS | News | $93.08 -0.13% 0.86% 1.2M |

Health Technology

| 13.99% | O: 0.07% H: 0.0% C: 0.0%
JNJ | News | $144.77 0.22% -0.01% 9.3M |

Health Technology

| -14.17% | O: 1.35% H: 0.0% C: 0.0%
GSK | $39.6 -0.88% 0.0% 2.8M |

Health Technology

| -3.71% | O: -0.24% H: 0.0% C: 0.0%
ABBV | $164.25 1.05% -0.76% 4M |

Health Technology

| 19.13% | O: 1.05% H: 0.0% C: 0.0%
SNY | News | $46.125 0.71% 0.7% 3.7M |

Health Technology

| -5.57% | O: 1.39% H: 0.0% C: 0.0%
AZN | $68.53 0.39% 0.39% 3.7M |

Health Technology

| 12.19% | O: 0.59% H: 0.0% C: 0.0%
therapy market

---

Global Cancer Cachexia Market to Reach $2.7 Billion by 2026
Published: 2022-06-03 (Crawled : 14:00) - prnewswire.com
AZNCF | $135.305 -4.19% 1.1K |

Health Technology

| 5.12% | O: -0.4% H: 4.05% C: -1.35%
LLY | News | $750.77 0.54% -0.04% 3.1M |

Health Technology

| 140.88% | O: -2.25% H: 0.0% C: 0.0%
AVEO | $15.0 0.0% 0 |

Health Technology

| 255.33% | O: -0.71% H: 0.0% C: 0.0%
AZN | $68.53 0.39% 0.39% 3.7M |

Health Technology

| 2.67% | O: -0.56% H: 0.82% C: -0.64%
cancer market

---

Fortress Biotech to Present at the 21st Annual Needham Virtual Healthcare Conference
Published: 2022-04-07 (Crawled : 14:00) - biospace.com/
AZNCF | $135.305 -4.19% 1.1K |

Health Technology

| -1.68% | O: 1.45% H: 0.46% C: 0.19%
FBIO | $1.79 1.7% 1.68% 240K |

Health Technology

| 28.47% | O: 0.73% H: 0.72% C: 0.0%
AZN | $68.53 0.39% 0.39% 3.7M |

Health Technology

| -1.17% | O: 0.35% H: 2.64% C: 2.45%
conference biotech

---

Global CNS Therapeutics Market Report 2022 - CNS Therapeutics Exhibit Robust Opportunities amidst Rising Incidence of CNS Disorders
Published: 2022-03-22 (Crawled : 14:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| -9.05% | O: 0.9% H: 0.0% C: -8.17%
AZNCF | $135.305 -4.19% 1.1K |

Health Technology

| 11.1% | O: 2.88% H: 2.09% C: 2.09%
NVS | News | $93.08 -0.13% 0.86% 1.2M |

Health Technology

| 7.1% | O: -0.93% H: 0.0% C: 0.0%
GSK | $39.6 -0.88% 0.0% 2.8M |

Health Technology

| -7.33% | O: 0.79% H: 0.0% C: 0.0%
ABBV | $164.25 1.05% -0.76% 4M |

Health Technology

| 1.56% | O: 0.0% H: 0.16% C: -0.02%
SNY | News | $46.125 0.71% 0.7% 3.7M |

Health Technology

| -11.12% | O: 0.15% H: 0.0% C: 0.0%
NBIX M | $133.26 0.2% 0.2% 570K |

Health Technology

| 41.24% | O: 0.04% H: 1.77% C: 0.65%
AZN | $68.53 0.39% 0.39% 3.7M |

Health Technology

| 7.98% | O: 0.51% H: 0.0% C: 0.0%
ALKS | News | $24.05 1.18% 1.16% 2.3M |

Health Technology

| -8.19% | O: -0.19% H: 2.09% C: 1.01%
therapeutics report

---

Fortress Biotech Announces Virtual Two-Day Corporate Access Summit Hosted by B. Riley Securities on Tuesday, April 5 and Wednesday, April 6, 2022
Published: 2022-03-03 (Crawled : 14:00) - biospace.com/
AZNCF | $135.305 -4.19% 1.1K |

Health Technology

| 8.31% | O: -5.26% H: 0.0% C: 0.0%
FBIO | $1.79 1.7% 1.68% 240K |

Health Technology

| 4.76% | O: -7.74% H: 0.55% C: -2.58%
AZN | $68.53 0.39% 0.39% 3.7M |

Health Technology

| 10.32% | O: -2.63% H: 0.9% C: -0.3%
day ces biotech iot

---

Genprex Announces First Patient Dosed in Phase 1/2 Acclaim-1 Clinical Trial of REQORSA™ Immunogene Therapy in Combination with Tagrisso® to Treat Non-Small Cell Lung Cancer
Published: 2022-03-02 (Crawled : 14:00) - biospace.com/
AZNCF | $135.305 -4.19% 1.1K |

Health Technology

| 10.91% | O: 0.37% H: 2.02% C: 2.02%
GNPX | $2.26 -1.74% -1.77% 21K |

Health Technology

| 0.88% | O: 3.95% H: 5.06% C: -7.17%
AZN | $68.53 0.39% 0.39% 3.7M |

Health Technology

| 9.64% | O: -0.62% H: 0.0% C: 0.0%
tagrisso gene therapy trial cel lung cancer phase 1 therapy cancer

---

Gainers vs Losers

56%

44%

Top 10 Gainers

INVO | $1.76 131.58% 56.82% 230M |

Health Technology

SINT | $0.0365 59.39% 37.26% 470M |

Health Technology

WISA 4 | $9.19 50.66% 33.7% 65M |

Electronic Technology

EDBL | News | $6.73 47.91% 32.39% 13M |

GCTK | $0.715 36.27% 26.62% 640K |

Manufacturing

TCON | $2.33 36.26% 26.61% 2M |

Health Technology

TIRX | $0.48 6.43% 24.58% 4.8M |

KZIA | $0.38 30.58% 23.42% 300K |

Health Technology

VNDA | News | $5.23 29.14% 22.56% 24M |

Health Technology

ATNF | $1.91 29.05% 22.51% 310K |

---

Your saved searches

---